Advertisement
U.S. markets close in 2 hours 57 minutes
  • S&P 500

    5,251.03
    +2.54 (+0.05%)
     
  • Dow 30

    39,774.57
    +14.49 (+0.04%)
     
  • Nasdaq

    16,376.40
    -23.12 (-0.14%)
     
  • Russell 2000

    2,128.79
    +14.44 (+0.68%)
     
  • Crude Oil

    82.75
    +1.40 (+1.72%)
     
  • Gold

    2,241.10
    +28.40 (+1.28%)
     
  • Silver

    24.98
    +0.22 (+0.90%)
     
  • EUR/USD

    1.0803
    -0.0027 (-0.25%)
     
  • 10-Yr Bond

    4.1910
    -0.0050 (-0.12%)
     
  • GBP/USD

    1.2635
    -0.0003 (-0.03%)
     
  • USD/JPY

    151.3410
    +0.0950 (+0.06%)
     
  • Bitcoin USD

    70,725.40
    +1,523.62 (+2.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

SQBG, CYDY & RIDE Deadline Alerts: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 12, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Sequential Brands Group, Inc. (NASDAQ:SQBG)

Class Period: November 3, 2016 - December 11, 2020

Deadline: May 17, 2021

For more info:www.bgandg.com/sqbg

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) in late 2016, the Company knew or should have known that its goodwill was likely impaired; (2) the Company avoided and delayed the material write down to goodwill in late 2016 through 2017; (3) the Company understated its operating expenses and net loss and also materially overstated its income from operations, goodwill, and assets from late 2016 through 2017; (4) the Company's internal controls were deficient; (5) the Company has failed to restate, correct, or disclose relevant improprieties, deceptive conduct, misstatements, omissions, and control violations; (6) as a result of the foregoing, the Company was at greater risk of regulatory scrutiny and enforcement; and (7) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

CytoDyn, Inc. (OTCMKT:CYDY)

Class Period: March 27, 2020 - March 9, 2021

Deadline: May 17, 2021

For more info:www.bgandg.com/cydy

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) while CytoDyn's stock price was sufficiently pumped with the COVID-19 cure hype, long-term shareholders, including CEO Nader Z. Pourhassan and CFO Michael Mulholland, dumped millions of shares; (2) CytoDyn engaged in a wrongful scheme with its lender, Iliad Research and Trading L.P. ("Iliad"), and its principal John Fife ("Fife"), whereby Iliad and other Fife entities operated as an unregistered securities dealer for CytoDyn; and (3) Iliad obtained a convertible promissory note from CytoDyn and converted the note into newly issued shares of CytoDyn and sold those shares into the public market at a profit, in violation of the dealer registration requirements of the federal securities laws.

Lordstown Motors Corp. (NASDAQ:RIDE)

Class Period: August 3, 2020 - March 24, 2021

Deadline: May 17, 2021

For more info:www.bgandg.com/ride
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: Specifically, the complaint alleges that BELLUS (1) deceived the investing public about its business, operations, drug products, drug product development, competition, and present and future business prospects; (2) facilitated the Company's September 2019 public offering ("Offering"); (3) created artificial demand for the BELLUS common shares sold in the Offering; (4) enabled the Company to receive approximately $70 million in net proceeds from the sale of BELLUS common stock in the Offering; and (5) caused Plaintiff and the Class to purchase BELLUS publicly traded common stock at artificially inflated prices.

CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/646415/SQBG-CYDY-RIDE-Deadline-Alerts-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-of-Class-Actions-and-Encourages-Investors-to-Contact-the-Firm

Advertisement